The abstract is read at the publisher; the summary is JClub's.
Primary aldosteronism is reviewed across epidemiology, screening, diagnosis, and treatment, highlighting medication management strategies for affected patients.
- Why it matters: Clinicians need clear guidance to identify primary aldosteronism and choose effective treatment, addressing gaps in practical diagnosis and management.
- What they did: This JAMA Insights article synthesizes evidence on screening approaches, diagnostic evaluation, and treatment options, with emphasis on medication management.
- The result: The review consolidates actionable considerations that can support more consistent diagnosis and treatment planning for patients with primary aldosteronism.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.